The role of piRNAs in cancer often involves more than one cancer hallmark—for example, in multiple myeloma (MM), piR-823 inhibited tumor formation in vitro and in vivo and induced the expression of cell cycle regulators and apoptosis-related proteins as well as the secretion of vascular endothelial growth factor. This evidence concerns the gene VEGFA and cancer.